Emerging Topical Onychomycosis Therapies - Quo Vadis?

被引:7
|
作者
Elkeeb, Rania [1 ]
Hui, Xiaoying [1 ]
Murthy, Narasimha [2 ]
Maibach, Howard I. [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA 94143 USA
[2] Univ Mississippi, Dept Pharmaceut & Drug Delivery, University, MS 38677 USA
关键词
emerging therapies; nail penetration; onychomycosis; topical; ungual drug delivery; NAIL LACQUER; TERBINAFINE; PERMEATION; CICLOPIROX; DELIVERY;
D O I
10.1517/14728214.2014.975206
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Onychomycosis, a common chronic fungal infection affecting fingernails and toenails, globally may affect 10 - 30% of the population. This chronic disease is difficult to eradicate. The goal of developing a highly effective and safe topical treatment has not yet been reached as it depends on the type of onychomycosis and the variety of invaders. Areas covered: Topical drug delivery to the nail is highly desirable in treating nail disorders. However, efficacy of topical therapies is low due to their limited permeability across the nail plate. Advances have especially been made by the development of new therapeutic options including new drug entities, new formulations and reformulations. This overview updates emerging topical treatments for onychomycosis, research progress and future perspectives. Expert opinion: Development of novel effective noninvasive topical therapy for treating onychomycosis and other nail diseases such as psoriasis is long overdue. Previously there was a lack of basic knowledge about nail and its barrier properties, but with the recent increased interest in this field both from industry and academia, we hope extensive research will continue in this field to bring about successful and safe treatments for such chronic diseases.
引用
收藏
页码:489 / 495
页数:7
相关论文
共 50 条
  • [1] ADOPTIVE THERAPIES - QUO-VADIS
    CLARK, JW
    LONGO, DL
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 442 - 458
  • [2] Quo Vadis? Topics, Theories, Tools, Therapies
    Szerlip, Nicholas J.
    Lonser, Russell R.
    FUTURE NEUROLOGY, 2006, 1 (02) : 149 - 151
  • [3] The use of topical therapies to treat onychomycosis
    Gupta, AK
    Ryder, JE
    Baran, R
    DERMATOLOGIC CLINICS, 2003, 21 (03) : 481 - +
  • [5] Development of Antibody-Directed Therapies: Quo Vadis?
    Rodrigues, Tiago
    Bernardes, Goncalo J. L.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (08) : 2032 - 2034
  • [6] Surgery Minimally Invasive Therapies in Gynecology - quo vadis?
    Solomayer, Erich-Franz
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2015, 75 (11) : 1109 - 1111
  • [7] Emerging therapies for the treatment of ungual onychomycosis
    Kushwaha, Avadhesh
    Murthy, Reena N.
    Murthy, S. Narasimha
    Elkeeb, Rania
    Hui, X.
    Maibach, Howard I.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (10) : 1575 - 1581
  • [8] Quo vadis, Kohorte?Quo vadis cohorts?
    I. Pigeot
    W. Ahrens
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2012, 55 : 753 - 755
  • [9] Quo vadis, Proktologe?Quo vadis, proctologist?
    Michael H. Roblick
    coloproctology, 2023, 45 (4) : 219 - 220
  • [10] Quo vadis university? (Quo vadis universidad?)
    Sancho-Gil, Juana M.
    CULTURE EDUCATION, 2021, 33 (02): : 397 - 411